In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More
1 year ago
6
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) and BIV201 for Refractory Ascites and HRS-AKI. Visit https://bit.ly/BioVie to learn more.
Loading comments...
-
DVR
Bannons War Room
10 days agoWarRoom Live
2.67M446 -
16:06
The Rubin Report
15 hours agoProof the Islamist Threat in England Can No Longer Be Ignored | Winston Marshall
91.1K82 -
2:07:07
Robert Gouveia
12 hours agoFBI Files Coverup! Bondi FURIOUS; SCOTUS Stops Judge; Special Counsel; FBI Does
116K87 -
56:15
Candace Show Podcast
12 hours agoBREAKING: My FIRST Prison Phone Call With Harvey Weinstein | Candace Ep 153
173K114 -
1:56:39
Flyover Conservatives
11 hours agoROBIN D. BULLOCK | Prophetic Warning: 2030 Is Up for Grabs – If We Don’t Act Now, Disaster Awaits! | FOC SHOW
60.8K12 -
2:13:11
megimu32
9 hours agoON THE SUBJECT: The Epstein List & Disney Channel Original Movies Nostalgia!!
46.6K6 -
9:06
Colion Noir
18 hours agoKid With Gun Shoots & Kills 2 Armed Robbers During Home Invasion
58.3K13 -
54:28
LFA TV
1 day agoUnjust Man | TRUMPET DAILY 2.27.25 7PM
59.5K5 -
1:36:39
Redacted News
12 hours agoBOMBSHELL EPSTEIN SH*T SHOW JUST DROPPED ON WASHINGTON, WHAT IS THIS? | Redacted w Clayton Morris
184K310 -
2:03:31
Revenge of the Cis
14 hours agoEpisode 1453: Fat & Fit
68.3K9